Overview

Esmolol for Treatment of Perioperative Tachycardia

Status:
Terminated
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if Esmolol is a safe and effective alternative treatment compared to standard treatment using a long acting beta blocker drug, in controlling abnormal heart rate before, during and immediately after surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Duke University
Collaborator:
Baxter Healthcare Corporation
Treatments:
Esmolol